Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2025 Earnings Call Transcript
Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology Inc. (VIR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 2,380,715 | $14,355,711 | 0.29% | |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,368,474 | $8,251,898 | 0.01% | |
| 3. | Hudson Bay Capital Management Sander Gerber | 1,325,000 | $7,989,750 | +46% | 0.03% |
| 4. | Millennium Management Israel Englander | 1,002,606 | $6,045,714 | -29% | 0% |
| 5. | GordonMD Global Investments Craig Gordon | 930,317 | $5,609,812 | 4.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.73 | 2,500 | $56,815.50 | 10,000 | 2023-03-01 | Filing | |
| $24.96 | 2,500 | $62,395.50 | 7,500 | 2023-01-05 | Filing | |
| $25.25 | 2,500 | $63,136.25 | 5,000 | 2023-01-04 | Filing | |
| $25.60 | 2,500 | $63,992.50 | 2,500 | 2023-01-03 | Filing | |
| $43.39 | 12 | $499.85 | 12 | 2021-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.45 | 1,829 | $13,631.17 | 71,043 | 2026-02-23 | Filing | |
| $7.45 | 2,089 | $15,568.90 | 164,249 | 2026-02-23 | Filing | |
| $7.45 | 2,089 | $15,568.90 | 157,529 | 2026-02-23 | Filing | |
| $7.45 | 4,445 | $33,127.70 | 129,799 | 2026-02-23 | Filing | |
| $7.45 | 19,039 | $141,893.86 | 1,035,466 | 2026-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,330,103 | $98,470,521 | 0% | |
| 2. | 13,116,977 | $79,095,371 | 0.79% | |
| 3. | 12,916,663 | $77,887,478 | 11.95% | |
| 4. | 12,548,944 | $75,670,133 | 0% | |
| 5. | 8,550,954 | $51,562,253 | 6.45% |
News See All
Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2025 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology's Second Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2025 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology's First Quarter 2025 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s Fourth Quarter and Full Year 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Why These 15 Stocks Are Skyrocketing in 2025
The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 billion in market value are attracting renewed interest.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript
Operator: [Call starts abruptly] …Vir's Third Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s Second Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc.
Hedge Fund Resource Center